SEARCH

SEARCH BY CITATION

References

  • Dispenzieri, A., Katzmann, J., Kyle, R., Larson, 3rd, D., Melton, L.J. 3rd., Colby, C., Therneau, T., Clark, R., Kumar, S., Bradwell, A., Fonseca, R., Jelinek, D. & Rajkumar, S. (2010) Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance (LC-MGUS): a newly defined entity. Lancet, 375, 17211728.
  • Drayson, M., Tang, L., Drew, R., Mead, G., Carr-Smith, H. & Bradwell, A. (2001) Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood, 97, 29002902.
  • Katzmann, J., Abraham, R., Dispenzieri, A., Lust, J. & Kyle, R. (2005) Diagnostic performance of quantitative serum free light chain assays in clinical practice. Clinical Chemistry, 51, 878881.
  • Kyle, R., Therneau, T., Rajkumar, S., Offord, J., Larson, D., Plevak, M. & Melton, L.J. 3rd. (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 346, 564569.
  • Kyle, R., Therneau, T., Rajkumar, S., Larson, D., Plevak, M., Offord, J., Dispenzieri, A., Katzmann, 3rd, J. & Melton, L.J. 3rd. (2006) Prevalence of monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 354, 13621639.
  • Landgren, O., Gridley, G., Turesson, I., Caporaso, N., Goldin, L., Baris, D., Fears, T., Hoover, R. & Linet, M. (2006) Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood, 107, 904906.
  • Landgren, O., Katzmann, J., Hsing, A., Pfeiffer, R., Kyle, R., Yeboah, E., Biritwum, R., Tettey, Y., Adjeu, A., Larson, D., Dispenzieri, 3rd, A., Melton, L.J. 3rd., Goldin, L., McMaster, M., Caporaso, N. & Rajkumar, S. (2007) Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clinic Proceedings, 82, 14681473.
  • Rajkumar, S., Kyle, R., Therneau, 3rd, T., Melton, L.J. 3rd., Bradwell, A., Clark, R., Larson, D., Plevak, M., Dispenzieri, A. & Katzmann, J. (2005) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined signficance. Blood, 106, 812817.
  • Vachon, C., Kyle, R., Therneau, T., Foreman, B., Larson, D., Colby, C., Phelps, T., Dispenzieri, A., Kumar, S., Katzmann, J. & Rajkumar, S. (2009) Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood, 114, 785790.